510(k) Report

510(k) · Cleared

Cleared

VaporShield

K250847510(k) TraditionalCleared Dec 12, 2025267-day reviewClass II21 CFR 880.5860

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Vault Paragon Group, Inc. · MEG Syringe, Antistick

Cleared on Dec 12, 2025 as substantially equivalent to K220114 (Vault Paragon Group, Inc., 2023) after a 267-day review. Its family tree reaches back 3 generations to 1998.

Decided
Dec 12, 2025
Review
267 days
Class
Class II
Product code
MEG
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K980069 (1998). 5 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2001: 1 other ancestor1998: 1 other ancestorK980069 · Vanishpoint Syringe · Retractable Technologies, Inc. · 1998K023752 · BD Integra Syringe · Bd · 2003 · recalledK220114 · PowerPAK Syringe · Vault Paragon Group, Inc. · 20231995200020052010201520202025
  1. Root · 3 generations backK980069 Vanishpoint SyringeRetractable Technologies, Inc. · 1998
  2. 2 generations backK023752 BD Integra SyringeBd · 2003 · Recalled
  3. 1 generation backK220114 PowerPAK SyringeVault Paragon Group, Inc. · 2023
  4. This deviceK250847 VaporShieldVault Paragon Group, Inc. · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K980069Vanishpoint SyringeRetractable Technologies, Inc.1998—
−2K023752BD Integra SyringeBd20032
−1K220114PowerPAK SyringeVault Paragon Group, Inc.2023—
0 (this device)K250847VaporShieldVault Paragon Group, Inc.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199810
200110
FIG. 1 — Lineage of K250847, 1998–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MEG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MEG device

  1. #1 K192551 1ml Luer Slip or Luer Lock Syringe, Syringe…score 19.6 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K220114PowerPAK Syringe
Summary page 5
…gulation Product Code 510(K) Number Clearance Date PowerPAK Syringe 880.5860; 880.5570 MEG, FMF, FMI K220114 1/25/2023 Device Description The VaporShield closed system transfer device (CSTD) is sterile, for single use, and i…
Vault Paragon Group, Inc.2023—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 27 years and passes through 3 companies; a new generation was cleared every 5.0 years on median.
  • 1 of the 5 ancestors has a recall of any class.

How does its category compare?

All MEG devices

MEG Syringe, Antistick: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · MEG

1in 2025

2007: 82008: 42009: 22010: 22011: 52012: 52013: 12014: 52015: 72016: 32017: 32018: 12019: 42020: 42021: 52022: 132023: 52025: 12026 (partial year): 1
2007high 13 (2022) · low 0 (2024)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MEG

229in 2023

2007: 100 days median2008: 145 days median2011: 113 days median2012: 109 days median2014: 153 days median2015: 253 days median2016: 179 days median2017: 130 days median2019: 249 days median2020: 296 days median2021: 152 days median2022: 216 days median2023: 229 days median
2007high 296 (2020) · low 100 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MEG

1in 2024

2008: 12010: 12013: 52015: 12024: 1, 1 Class I
2007high 5 (2013) · low 0 (2007)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · MEG

148in 2025

2007: 212008: 202009: 262010: 342011: 342012: 222013: 272014: 362015: 512016: 942017: 1812018: 2692019: 4972020: 3532021: 5412022: 1702023: 1202024: 1122025: 148
2007high 541 (2021) · low 20 (2008)2025

MAUDE reports naming product code MEG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078100021
20084145120
20092—026
20102—134
20115113034
20125109022
20131—527
20145153036
20157253151
20163179094
201731300181
20181—0269
201942490497
202042960353
202151520541
2022132160170
202352290120
20240—1 (1)112
20251—0148
20261—0—

What is it indicated for?

The VaporShield™ is a sterile, single-use, closed system transfer device (CSTD), incorporating a preassembled Drug Vial holder (DVH) and Syringe (1mL, 22GA). The preassembled device is intended for medication draw from a drug vial only. After medication draw, the DVH is removed from the syringe, and the syringe is used for direct injection of hazardous and non-hazardous medication via subcutaneous or intramuscular administration. The syringe incorporates…

Read the full statement (166 words)

The VaporShield™ is a sterile, single-use, closed system transfer device (CSTD), incorporating a preassembled Drug Vial holder (DVH) and Syringe (1mL, 22GA). The preassembled device is intended for medication draw from a drug vial only. After medication draw, the DVH is removed from the syringe, and the syringe is used for direct injection of hazardous and non-hazardous medication via subcutaneous or intramuscular administration. The syringe incorporates a safety mechanism which automatically retracts the needle inside the device for drug containment, and prevention of accidental needlesticks and device reuse. The VaporShield mechanically prevents drug transfer external to the device to minimize individual and environmental drug exposure. The VaporShield is intended for use by medical professionals who prepare/administer injection(s) to adults and adolescents in healthcare facilities. The device is not intended for neonates (<28 days old), infants (< 2 yrs old), or children (> 2 yrs. old – 12 yrs. old). The VaporShield Device is not intended for Compounding, Reconstitution, Phlebotomy, Intravenous injection, Intraperitoneal injection, or Intrathecal injection.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K250847: VaporShield.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K250847

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026